Published in Nucleic Acids Res on November 11, 1993
The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization. RNA (1997) 1.84
Comparative analysis of cleavage rates after systematic permutation of the NUX consensus target motif for hammerhead ribozymes. Nucleic Acids Res (1995) 1.10
Vaccinia virion protein I8R has both DNA and RNA helicase activities: implications for vaccinia virus transcription. J Virol (1996) 1.08
Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes. Proc Natl Acad Sci U S A (1998) 1.04
Efficient hammerhead ribozyme-mediated cleavage of the structured hepatitis B virus encapsidation signal in vitro and in cell extracts, but not in intact cells. Nucleic Acids Res (1995) 1.02
Dissociation of long-chain duplex RNA can occur via strand displacement in vitro: biological implications. Nucleic Acids Res (1996) 1.00
A three-nucleotide helix I is sufficient for full activity of a hammerhead ribozyme: advantages of an asymmetric design. Nucleic Acids Res (1994) 0.97
The effect of structure in a long target RNA on ribozyme cleavage efficiency. Nucleic Acids Res (1997) 0.93
The subcellular localization and length of hammerhead ribozymes determine efficacy in human cells. Nucleic Acids Res (1997) 0.93
Extension of helix II of an HIV-1-directed hammerhead ribozyme with long antisense flanks does not alter kinetic parameters in vitro but causes loss of the inhibitory potential in living cells. Nucleic Acids Res (1994) 0.90
Oligonucleotide facilitators may inhibit or activate a hammerhead ribozyme. Nucleic Acids Res (1996) 0.89
A spermidine-induced conformational change of long-armed hammerhead ribozymes: ionic requirements for fast cleavage kinetics. Nucleic Acids Res (1997) 0.88
Intracellular ribozyme-catalyzed trans-cleavage of RNA monitored by fluorescence resonance energy transfer. RNA (2000) 0.85
tRNAVal-heterodimeric maxizymes with high potential as geneinactivating agents: simultaneous cleavage at two sites in HIV-1 Tat mRNA in cultured cells. Proc Natl Acad Sci U S A (1999) 0.85
Efficient and specific ribozyme-mediated reduction of bovine alpha-lactalbumin expression in double transgenic mice. Proc Natl Acad Sci U S A (1996) 0.80
A new antisense tRNA construct for the genetic treatment of human immunodeficiency virus type 1 infection. J Virol (1996) 0.80
Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates. Nucleic Acids Res (1997) 0.79
Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science (1984) 33.32
Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature (1985) 30.62
Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res (1990) 20.53
On finding all suboptimal foldings of an RNA molecule. Science (1989) 20.36
Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol (1986) 16.65
Improved predictions of secondary structures for RNA. Proc Natl Acad Sci U S A (1989) 11.52
Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature (1988) 8.74
A small catalytic oligoribonucleotide. Nature (1987) 8.73
Immunopurification of heterogeneous nuclear ribonucleoprotein particles reveals an assortment of RNA-binding proteins. Genes Dev (1988) 5.73
Role of T3 surface molecules in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium. Proc Natl Acad Sci U S A (1984) 4.66
Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology (1983) 4.11
Human hepatitis delta virus RNA subfragments contain an autocleavage activity. Proc Natl Acad Sci U S A (1989) 3.51
Sequence-specific endoribonuclease activity of the Tetrahymena ribozyme: enhanced cleavage of certain oligonucleotide substrates that form mismatched ribozyme-substrate complexes. Biochemistry (1988) 3.33
Satellite tobacco ringspot virus RNA: A subset of the RNA sequence is sufficient for autolytic processing. Proc Natl Acad Sci U S A (1986) 3.24
Substrate sequence effects on "hammerhead" RNA catalytic efficiency. Proc Natl Acad Sci U S A (1990) 2.81
Numbering system for the hammerhead. Nucleic Acids Res (1992) 2.74
Renaturation of complementary DNA strands mediated by purified mammalian heterogeneous nuclear ribonucleoprotein A1 protein: implications for a mechanism for rapid molecular assembly. Proc Natl Acad Sci U S A (1990) 2.31
Ribozyme mediated destruction of RNA in vivo. EMBO J (1989) 2.22
Substrate specificity of the dsRNA unwinding/modifying activity. EMBO J (1991) 2.18
Double-stranded RNA unwinding and modifying activity is detected ubiquitously in primary tissues and cell lines. Mol Cell Biol (1990) 1.89
Specific gene suppression by engineered ribozymes in monkey cells. Proc Natl Acad Sci U S A (1989) 1.82
Evidence that genomic and antigenomic RNA self-cleaving elements from hepatitis delta virus have similar secondary structures. Nucleic Acids Res (1991) 1.63
Inhibition of heterologous strains of HIV by antisense RNA. AIDS (1991) 1.55
Ribozyme, antisense RNA, and antisense DNA inhibition of U7 small nuclear ribonucleoprotein-mediated histone pre-mRNA processing in vitro. Mol Cell Biol (1989) 1.48
Ribozymes correctly cleave a model substrate and endogenous RNA in vivo. J Biol Chem (1990) 1.44
Ribozymes that cleave an RNA sequence from human immunodeficiency virus: the effect of flanking sequence on rate. Arch Biochem Biophys (1991) 1.38
Preformed ribozyme destroys tumour necrosis factor mRNA in human cells. J Mol Biol (1992) 1.20
Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA. J Gen Virol (1990) 1.20
Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA. Virology (1992) 1.20
Development of techniques to analyse the formation of HIV provirus in primary human macrophages. Res Virol (1991) 1.19
Identification and analysis of antisense RNA target regions of the human immunodeficiency virus type 1. Nucleic Acids Res (1991) 1.14
The isolation and characterization of an RNA helicase from nuclear extracts of HeLa cells. J Biol Chem (1991) 1.08
A rat CD4 mutant containing the gp120-binding site mediates human immunodeficiency virus type 1 infection. J Exp Med (1993) 1.07
Antigenomic Hepatitis delta virus ribozymes self-cleave in 18 M formamide. Nucleic Acids Res (1991) 1.02
Strand specific cleavage of phosphorothioate-containing DNA by reaction with restriction endonucleases in the presence of ethidium bromide. Nucleic Acids Res (1988) 0.98
Studies on nucleic acid reassociation kinetics: V. Effects of disparity in tracer and driver fragment lengths. Nucleic Acids Res (1978) 0.97
An anti-lymphocytic choriomeningitis virus ribozyme expressed in tissue culture cells diminishes viral RNA levels and leads to a reduction in infectious virus yield. J Virol (1993) 0.84
Gene inhibition of HIV-1 replication. A comparative and mechanistic study. Ann N Y Acad Sci (1992) 0.80
Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature (1988) 6.12
Melanopsin and rod-cone photoreceptive systems account for all major accessory visual functions in mice. Nature (2003) 5.84
Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science (1991) 5.82
Intensive versus standard case management for severe psychotic illness: a randomised trial. UK 700 Group. Lancet (1999) 4.54
Vibrio parahaemolyticus infections in the United States, 1973-1998. J Infect Dis (2000) 4.35
Handheld cellular telephone use and risk of brain cancer. JAMA (2000) 3.59
National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project. JAMA (1990) 3.25
Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clin Infect Dis (2001) 3.08
Mapping of antigenic and functional epitopes on the alpha- and beta-subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and Mac-1. J Exp Med (1983) 2.78
Discrepancies in tuberculin skin test results with two commercial products in a population of intravenous drug users. J Infect Dis (1993) 2.77
Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J Immunol (1992) 2.64
pop-1 encodes an HMG box protein required for the specification of a mesoderm precursor in early C. elegans embryos. Cell (1995) 2.61
The role of Gulf Coast oysters harvested in warmer months in Vibrio vulnificus infections in the United States, 1988-1996. Vibrio Working Group. J Infect Dis (1998) 2.46
Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study. BMJ (1996) 2.27
Randomised controlled trial of treatment of chronic suppurative otitis media in Kenyan schoolchildren. Lancet (1996) 2.16
Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study. Psychol Med (2003) 2.16
Production of cloned pigs from in vitro systems. Nat Biotechnol (2000) 2.15
Poly(A) site selection in the HIV-1 provirus: inhibition of promoter-proximal polyadenylation by the downstream major splice donor site. Genes Dev (1995) 2.13
The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection. N Engl J Med (1994) 2.08
Frequency-Dependent Selection for Plasmid-Containing Cells of ESCHERICHIA COLI. Genetics (1979) 2.07
A dual-radioisotope technique for the evaluation of penile blood flow during tumescence. J Nucl Med (1992) 2.04
The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins. Mol Cell Biol (1994) 2.03
Perioperative corticosteroid supplementation and dento-alveolar surgery. Dent Update (2003) 2.02
Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol (1985) 1.92
Physicians promoting bicycle helmets for children: a randomized trial. Am J Public Health (1991) 1.90
Decline in prevalence of neural tube defects in a high-risk region of the United States. Pediatrics (2000) 1.85
The pdr12 ABC transporter is required for the development of weak organic acid resistance in yeast. EMBO J (1998) 1.83
Cardiovascular risk factors for people with mental illness. Aust N Z J Psychiatry (2001) 1.81
Urethral insertion of foreign bodies. A report of contagious self-mutilation in a maximum-security hospital. Arch Gen Psychiatry (1982) 1.80
Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem Pharmacol (1994) 1.76
Aminopyridine block of transient potassium current. J Gen Physiol (1982) 1.73
Identification and regulation of the cystic fibrosis transmembrane conductance regulator-generated chloride channel. J Clin Invest (1991) 1.71
Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo. J Bone Miner Res (1997) 1.63
Towards a genetic dissection of the basis of triplet decoding, and its natural subversion: programmed reading frame shifts and hops. Annu Rev Genet (1991) 1.62
The 58-kilodalton inhibitor of the interferon-induced double-stranded RNA-activated protein kinase is a tetratricopeptide repeat protein with oncogenic properties. Proc Natl Acad Sci U S A (1994) 1.57
Inhibition of heterologous strains of HIV by antisense RNA. AIDS (1991) 1.55
Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis. Thorax (2002) 1.54
Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation. Mol Cell Biol (1995) 1.53
The nucleotide sequence of the first externally suppressible--1 frameshift mutant, and of some nearby leaky frameshift mutants. EMBO J (1983) 1.52
Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Science (1995) 1.48
Presence of antibodies to the major anaerobically induced gonococcal outer membrane protein in sera from patients with gonococcal infections. Microb Pathog (1988) 1.48
Gender differences in smoking and risk for oral cancer. Cancer Res (1996) 1.47
Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction. Eur Heart J (2001) 1.47
Obstacles to timely neonatal screening in North Thames. J Med Screen (1998) 1.47
Assessing the needs of breast cancer patients and their families. Qual Manag Health Care (1993) 1.43
Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking. Cancer (1997) 1.42
Stimulus equivalence and rule following. J Exp Anal Behav (1989) 1.41
Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis. Cancer Res (1994) 1.41
Manual-assisted cognitive-behaviour therapy (MACT): a randomized controlled trial of a brief intervention with bibliotherapy in the treatment of recurrent deliberate self-harm. Psychol Med (1999) 1.39
Science's great tragedy. Aust N Z J Public Health (1998) 1.39
Are herbal teas safe for infants and children? Aust Fam Physician (1989) 1.38
Mutants of elongation factor Tu promote ribosomal frameshifting and nonsense readthrough. EMBO J (1987) 1.36
A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic response. Cancer Chemother Pharmacol (1989) 1.36
Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: a decision-making approach. Psychol Med (2003) 1.35
An N-Terminal Dimerization Domain Permits Homeodomain Proteins To Choose Compatible Partners and Initiate Sexual Development in the Mushroom Coprinus cinereus. Plant Cell (1995) 1.33
The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance? British Family Heart Study Group. Br J Gen Pract (1996) 1.31
Assessment of ventricular size and function in congenitally corrected transposition of the great arteries. Am J Cardiol (1983) 1.28
Handheld cellular telephones and risk of acoustic neuroma. Neurology (2002) 1.27
Cytotoxic chemotherapy for advanced renal cell carcinoma. Urol Clin North Am (1993) 1.27
Disparity in glycemic control and adherence between African-American and Caucasian youths with diabetes. Family and community contexts. Diabetes Care (1997) 1.26
The role of oil and agalactosyl IgG in the induction of arthritis in rodent models. Eur J Immunol (1991) 1.25
Aeolian processes at the Mars Exploration Rover Meridiani Planum landing site. Nature (2005) 1.23
Pleomorphic xanthoastrocytoma: favorable outcome after complete surgical resection. Neuro Oncol (2001) 1.22
Sound alters visual evoked potentials in humans. Neuroreport (2001) 1.22
The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding. J Virol (1995) 1.21
Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA. J Gen Virol (1990) 1.20
Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community. J Urban Health (1999) 1.19
Characterization of the human trophoblast-leukocyte antigenic molecules defined by a monoclonal antibody. J Immunol (1986) 1.19
Cigarette smoking and tuberculin skin test conversion among incarcerated adults. Am J Prev Med (1997) 1.19
Development of techniques to analyse the formation of HIV provirus in primary human macrophages. Res Virol (1991) 1.19
The role of epidermal aryl hydrocarbon hydroxylase in the covalent binding of polycyclic hydrocarbon to DNA and its relationship to tumor initiation. Biochem Biophys Res Commun (1976) 1.18
Human erythrocyte fraction in "Percoll" density gradients. Clin Chim Acta (1979) 1.17
Novobiocin precipitates histones at concentrations normally used to inhibit eukaryotic type II topoisomerase. Nucleic Acids Res (1986) 1.17
Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica. JAMA (1999) 1.16
OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand. Eur J Immunol (1996) 1.15
Treating gonococcal infections resistant to penicillin in Bangkok: comparison of cefuroxime and spectinomycin. Genitourin Med (1985) 1.14
Cell-surface heparan sulfate facilitates human immunodeficiency virus Type 1 entry into some cell lines but not primary lymphocytes. Virus Res (1999) 1.14
Cutting edge: novel RNA ligands able to bind CD4 antigen and inhibit CD4+ T lymphocyte function. J Immunol (1998) 1.11
Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation. Proc Natl Acad Sci U S A (1993) 1.11
Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro. J Exp Med (1993) 1.11
Reye-like syndrome associated with use of insect repellent in a presumed heterozygote for ornithine carbamoyl transferase deficiency. J Pediatr (1980) 1.10
Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial. Lancet (2001) 1.10
Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases. Eur J Cardiovasc Prev Rehabil (2007) 1.10
Paraplegia following intrathecal chemotherapy. Cancer (1972) 1.09
The physical bases of emotion. 1894. Psychol Rev (1994) 1.08
A rat CD4 mutant containing the gp120-binding site mediates human immunodeficiency virus type 1 infection. J Exp Med (1993) 1.07
Unequal pupils. A flow chart for sorting out the anisocorias. Surv Ophthalmol (1976) 1.07
The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding. Antiviral Res (1996) 1.06
p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate. J Urol (1992) 1.06
Water-borne outbreak of Campylobacter laridis-associated gastroenteritis. Lancet (1987) 1.06
Silent lacunar lesions detected by magnetic resonance imaging of children with brain tumors: a late sequela of therapy. J Clin Oncol (2000) 1.06
Affinity and kinetics of the interaction between soluble trimeric OX40 ligand, a member of the tumor necrosis factor superfamily, and its receptor OX40 on activated T cells. J Biol Chem (1997) 1.04
A new percutaneous technique for establishing venous bypass access in orthotopic liver transplantation. J Cardiothorac Vasc Anesth (1994) 1.04
Virtual outreach: a randomised controlled trial and economic evaluation of joint teleconferenced medical consultations. Health Technol Assess (2004) 1.04
A prevalence study of ear problems in school children in Kiambu district, Kenya, May 1992. Int J Pediatr Otorhinolaryngol (1995) 1.03